BlackRock’s MediciNova MNOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $993K | Buy |
752,091
+46,137
| +7% | +$63.3K | ﹤0.01% | 4356 |
|
|
2026
Q1 | $967K | Buy |
705,954
+984
| +0.1% | +$1.49K | ﹤0.01% | 4359 |
|
|
2025
Q4 | $924K | Buy |
704,970
+6,003
| +0.9% | +$8.28K | ﹤0.01% | 4326 |
|
|
2025
Q3 | $888K | Buy |
698,967
+3,252
| +0.5% | +$4.2K | ﹤0.01% | 4316 |
|
|
2025
Q2 | $911K | Sell |
695,715
-4,626
| -0.7% | -$6.48K | ﹤0.01% | 4282 |
|
|
2025
Q1 | $1.02M | Sell |
700,341
-1,450
| -0.2% | -$2.56K | ﹤0.01% | 4179 |
|
|
2024
Q4 | $1.47M | Buy |
701,791
+1,213
| +0.2% | +$2.37K | ﹤0.01% | 4123 |
|
|
2024
Q3 | $1.47M | Buy |
700,578
+5,635
| +0.8% | +$8.34K | ﹤0.01% | 4087 |
|
|
2024
Q2 | $1M | Sell |
694,943
-477
| -0.1% | -$668 | ﹤0.01% | 4180 |
|
|
2024
Q1 | $1.01M | Sell |
695,420
-4,222
| -0.6% | -$6K | ﹤0.01% | 4197 |
|
|
2023
Q4 | $1.05M | Buy |
699,642
+4,045
| +0.6% | +$7.31K | ﹤0.01% | 4237 |
|
|
2023
Q3 | $1.45M | Sell |
695,597
-35,772
| -5% | -$83.2K | ﹤0.01% | 4112 |
|
|
2023
Q2 | $1.68M | Buy |
731,369
+16,488
| +2% | +$36.3K | ﹤0.01% | 4128 |
|
|
2023
Q1 | $1.54M | Buy |
714,881
+3,099
| +0.4% | +$7.1K | ﹤0.01% | 4167 |
|
|
2022
Q4 | $1.46M | Buy |
711,782
+1,127
| +0.2% | +$2.49K | ﹤0.01% | 4266 |
|
|
2022
Q3 | $1.54M | Sell |
710,655
-4,708
| -0.7% | -$10.9K | ﹤0.01% | 4310 |
|
|
2022
Q2 | $1.81M | Sell |
715,363
-6,491
| -0.9% | -$16.9K | ﹤0.01% | 4293 |
|
|
2022
Q1 | $1.93M | Sell |
721,854
-10,038
| -1% | -$24.6K | ﹤0.01% | 4411 |
|
|
2021
Q4 | $1.96M | Sell |
731,892
-414,078
| -36% | -$1.38M | ﹤0.01% | 4411 |
|
|
2021
Q3 | $4.34M | Buy |
1,145,970
+18,048
| +2% | +$68.6K | ﹤0.01% | 4014 |
|
|
2021
Q2 | $4.79M | Sell |
1,127,922
-2,259,671
| -67% | -$9.73M | ﹤0.01% | 3897 |
|
|
2021
Q1 | $17.1M | Buy |
3,387,593
+73,622
| +2% | +$428K | ﹤0.01% | 3263 |
|
|
2020
Q4 | $17.4M | Buy |
3,313,971
+471,747
| +17% | +$2.7M | ﹤0.01% | 3082 |
|
|
2020
Q3 | $14.9M | Sell |
2,842,224
-21,451
| -0.7% | -$124K | ﹤0.01% | 3036 |
|
|
2020
Q2 | $15.5M | Buy |
2,863,675
+35,954
| +1% | +$191K | ﹤0.01% | 2936 |
|
|
2020
Q1 | $10.5M | Sell |
2,827,721
-7,869
| -0.3% | -$41K | ﹤0.01% | 2964 |
|
|
2019
Q4 | $19.1M | Sell |
2,835,590
-375,349
| -12% | -$2.82M | ﹤0.01% | 2911 |
|
|
2019
Q3 | $25.5M | Buy |
3,210,939
+75,628
| +2% | +$674K | ﹤0.01% | 2677 |
|
|
2019
Q2 | $30.2M | Buy |
3,135,311
+326,947
| +12% | +$3.45M | ﹤0.01% | 2610 |
|
|
2019
Q1 | $23.3M | Sell |
2,808,364
-104,881
| -4% | -$915K | ﹤0.01% | 2669 |
|
|
2018
Q4 | $23.8M | Buy |
2,913,245
+504,452
| +21% | +$5.03M | ﹤0.01% | 2630 |
|
|
2018
Q3 | $30.1M | Buy |
2,408,793
+33,377
| +1% | +$335K | ﹤0.01% | 2653 |
|
|
2018
Q2 | $18.9M | Buy |
2,375,416
+222,277
| +10% | +$2.3M | ﹤0.01% | 2897 |
|
|
2018
Q1 | $22M | Buy |
2,153,139
+441,945
| +26% | +$4.4M | ﹤0.01% | 2713 |
|
|
2017
Q4 | $11.1M | Sell |
1,711,194
-464,991
| -21% | -$3.08M | ﹤0.01% | 3094 |
|
|
2017
Q3 | $13.9M | Buy |
2,176,185
+68,726
| +3% | +$365K | ﹤0.01% | 2990 |
|
|
2017
Q2 | $11.1M | Buy |
2,107,459
+142,575
| +7% | +$799K | ﹤0.01% | 3112 |
|
|
2017
Q1 | $11.8M | Buy |
1,964,884
+1,963,764
| +175,336% | +$11.8M | ﹤0.01% | 3036 |
|
|
2016
Q4 | $7K | Hold |
1,120
| – | – | ﹤0.01% | 3464 |
|
|
2016
Q3 | $8K | Hold |
1,120
| – | – | ﹤0.01% | 3433 |
|
|
2016
Q2 | $8K | Buy |
+1,120
| New | +$8.1K | ﹤0.01% | 3448 |
|
Other funds holding MNOV
EWM
BlackRock's MNOV Position: Q2 2026 in Review
BlackRock increased its MediciNova (MNOV) stake by 6.5% in Q2 2026, buying an estimated $63.3K and bringing the position to 752,091 shares worth $993K. The position accounts for ﹤0.01% of the portfolio, ranked #4356.
BlackRock first reported a position in MNOV in Q2 2016 and has held it in 41 quarters since. The position peaked at $30.2M in Q2 2019. 28 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.
- BlackRock held 752,091 shares of MediciNova worth $993K as of Q2 2026.
- BlackRock bought 46,137 MediciNova shares in Q2 2026, an estimated $63.3K.
- MediciNova made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4356 holding.
- BlackRock first reported a position in MediciNova in Q2 2016 and has held it in 41 quarters since.
- BlackRock's MediciNova position peaked at $30.2M in Q2 2019.
- 28 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.